Orange CA 重度抑郁症临床试验
13项针对 重度抑郁症的研究正在 Orange及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
招募中2 期
- PNS Clinical Research LLC dba ATP Clinical Research, Orange
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
招募中3 期
- ATP Clinical Research, Orange
- NRC Research Institute, Orange
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
招募中3 期
- ATP Clinical Research Orange County, Orange
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
招募中3 期
- ATP Clinical Research, Orange
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
招募中3 期
- NRC Research Institute, Orange
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
招募中2 期
- Nrc Research Institute, Orange
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
招募中3 期
- Vanda Investigational Site, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
招募中4 期
- Neurocrine Clinical Site, Orange
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Atp Clinical Research, Orange
- Nrc Research Institute, Orange
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Orange
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Orange
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
招募中2 期
- Autobahn Site #152, Orange
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Orange
其他城市的 重度抑郁症试验
- New York City, NY36 项研究
- Boston, MA31 项研究
- Atlanta, GA25 项研究
- Philadelphia, PA23 项研究
- Orlando, FL19 项研究
- Miami, FL18 项研究
- Chicago, IL17 项研究
- Tampa, FL17 项研究
- Houston, TX16 项研究
- San Diego, CA16 项研究
- Little Rock, AR14 项研究
- Austin, TX13 项研究
Orange的其他研究
- 非小细胞肺癌25 项研究
- 转移性癌症20 项研究
- 结直肠癌16 项研究
- 卵巢癌16 项研究
- 胰腺癌15 项研究
- 黑色素瘤14 项研究
- 肝癌（肝细胞癌）14 项研究
- 乳腺癌14 项研究
- 肺癌14 项研究
- 前列腺癌14 项研究
- 胃癌13 项研究
- 癌症（所有类型）13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。